These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16796795

  • 21. [Capecitabine-induced hyperpigmentation].
    Vázquez-Bayo C, Rodríguez-Bujaldón AL, Jiménez-Puya R, Galán-Gutiérrez M, Moreno-Giménez JC.
    Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
    [Abstract] [Full Text] [Related]

  • 22. Capecitabine and sixth cranial nerve palsy.
    Dasgupta S, Adilieje C, Bhattacharya A, Smith B, Sheikh Mu.
    J Cancer Res Ther; 2010 Sep; 6(1):80-1. PubMed ID: 20479552
    [Abstract] [Full Text] [Related]

  • 23. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
    Bar-Sela G, Haim N.
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
    [Abstract] [Full Text] [Related]

  • 24. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
    Agharbi FZ, Meziane M, Benhemmne H, Daoudi K, Elmesbahi O, Mikou O, Mernissi FZ.
    Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
    [No Abstract] [Full Text] [Related]

  • 25. [Coronary insufficiency after an oral intake of capecitabine].
    Desramé J, Bronstein JA, Thiolet C, Bredin C, Ceccaldi B, Vergeau B, Farret O.
    Gastroenterol Clin Biol; 2001 Mar; 25(8-9):829-30. PubMed ID: 11598548
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N, Misra V.
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract] [Full Text] [Related]

  • 31. [The prevention of diarrhea while under capecitabine therapy].
    Grouls V.
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
    [No Abstract] [Full Text] [Related]

  • 32. Emerging role of capecitabine in gastric cancer.
    Comella P, Franco L, Casaretti R, de Portu S, Menditto E.
    Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Longitudinal melanonychia induced by capecitabine.
    Paravar T, Hymes SR.
    Dermatol Online J; 2009 Oct 15; 15(10):11. PubMed ID: 19951629
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Increased INR from concomitant use of acenocoumarol and capecitabine].
    Tomlow B, Voll ML, Smorenburg CH.
    Ned Tijdschr Geneeskd; 2012 Oct 15; 156(26):A4793. PubMed ID: 22759711
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.